tiprankstipranks
Lyra Therapeutics, Inc. (LYRA)
OTHER OTC:LYRA
US Market
LYRA
Lyra Therapeutics
RESEARCH TOOLSreports
Want to see LYRA full AI Analyst Report?

Lyra Therapeutics (LYRA) Income Statement

363 Followers

Lyra Therapeutics Income Statement

Last quarter (Q4 2025), Lyra Therapeutics's total revenue was $7.00K, a decrease of -96.65% from the same quarter last year. In Q4, Lyra Therapeutics's net income was $-6.95M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 398.00K$ 1.53M$ 1.56M$ 1.36M$ 285.00K
Gross Profit
$ 0.00$ 1.53M$ 1.56M$ 1.36M$ -29.41M
Operating Expenses
$ 31.42M$ 97.88M$ 68.68M$ 57.67M$ 14.21M
Depreciation and Amortization
$ 0.00$ 471.00K$ 278.00K$ 1.07M$ 1.00M
EBITDA
$ -31.02M$ -60.26M$ -65.25M$ -53.92M$ -42.61M
Operating Income
$ -31.02M$ -96.35M$ -67.12M$ -56.31M$ -43.62M
Other Income/Expenses
$ 2.11M$ 2.95M$ 4.50M$ 1.04M$ 102.00K
Pretax Income
$ -28.91M$ -93.40M$ -62.62M$ -55.27M$ -43.51M
Net Income
$ -28.92M$ -93.44M$ -62.68M$ -55.28M$ -43.51M
Per Share Metrics
Basic EPS
$ -18.62$ -1.43$ -1.26$ -1.83$ -3.35
Diluted EPS
$ -18.62$ -1.43$ -1.26$ -1.83$ -3.35
Weighted Average Shares Outstanding
 15.53M 65.11M 49.75M 30.24M 12.99M
Weighted Average Shares Outstanding (Diluted)
 15.53M 65.11M 49.80M 30.24M 12.99M
Currency in USD

Lyra Therapeutics Earnings and Revenue History